系统医学2024,Vol.9Issue(1) :195-198.DOI:10.19368/j.cnki.2096-1782.2024.01.195

EDAMS血管融合术在治疗烟雾病中的研究进展

Progress of EDAMS Vascular Fusion in the Treatment of Moyamoya Dis-ease

秦政 包金锁 王衍刚
系统医学2024,Vol.9Issue(1) :195-198.DOI:10.19368/j.cnki.2096-1782.2024.01.195

EDAMS血管融合术在治疗烟雾病中的研究进展

Progress of EDAMS Vascular Fusion in the Treatment of Moyamoya Dis-ease

秦政 1包金锁 2王衍刚3
扫码查看

作者信息

  • 1. 内蒙古民族大学临床医学院,内蒙古呼伦贝尔 021000;河南省焦作市人民医院神经外科,河南焦作 454000
  • 2. 内蒙古民族大学附属医院神经外科,内蒙古通辽 028000
  • 3. 河南省焦作市人民医院神经外科,河南焦作 454000
  • 折叠

摘要

烟雾病(Moyamoya Disease,MMD)是一类发病机制不清的脑血管病,其临床特点是双颈内动脉、大脑前动脉和中动脉长期进行性阻塞或狭窄,并可在颅腔内形成畸形的血管网络,使病变的血管网络出现"烟雾"状,故被称作"烟雾病".目前关于烟雾病的治疗方法多为间接或直接血管重建,或联合手术,但其效果和预后仍有很大争议.基于此,本文就脑-硬脑膜-颞肌环路术(Encephalo-Duro-Arterio-Myo-Synangiosis,EDAMS)血管融合术治疗烟雾病的研究进展进行综述.

Abstract

Moyamoya disease(MMD)is a type of cerebrovascular disease with unclear pathogenesis.It is character-ized by long-term progressive obstruction or stenosis of both internal carotid arteries,anterior cerebral arteries and middle arteries,and the formation of malformed vascular network in the cranial cavity,which makes the diseased vas-cular network appear as"smoke",and is therefore called"moyamoya disease".Currently,most of the treatments for MMD are indirect or direct revascularization,or combined with surgery,but the results and prognosis are still contro-versial.Based on this,this article provides a review of the research progress in the treatment of moyamoya disease us-ing encephalo-duro-arterio-myo-synangiosis(EDAMS)vascular fusion.

关键词

烟雾病/直接血管重建/间接血管重建/EDAMS血管融合术

Key words

Moyamoya disease/Direct revascularization/Indirect revascularization/EDAMS vascular fusion

引用本文复制引用

基金项目

河南省医学科技攻关计划联合共建项目(2019)(LHGJ20191341)

出版年

2024
系统医学

系统医学

ISSN:
参考文献量18
段落导航相关论文